Synthesis and Neurotoxicity of Tetrahydroisoquinoline Derivatives for Studying Parkinson's Disease

DOI Web Site Web Site PubMed 参考文献157件
  • Abe Kenji
    Department of Neuroscience, Showa Pharmaceutical University
  • Saitoh Toshiaki
    Department of Medicinal Chemistry, Showa Pharmaceutical University
  • Horiguchi Yoshie
    Department of Medicinal Chemistry, Showa Pharmaceutical University
  • Utsunomiya Iku
    Department of Neuroscience, Showa Pharmaceutical University
  • Taguchi Kyoji
    Department of Neuroscience, Showa Pharmaceutical University

この論文をさがす

説明

Parkinson's disease involves the progressive degeneration of dopaminergic neurons in the substantia nigra. However, the etiology of the disease remains to be elucidated. Endogenous amines, such as 1,2,3,4-tetrahydroisoquinoline (TIQ) derivatives present in the mammalian brain, are known to participate in the pathogenesis of Parkinson's disease. These endogenous neurotoxins have been extensively studied because of their structural resemblance to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), an agent widely used for generating animal models of Parkinson's disease-like symptoms. Investigations of the synthesis and pharmacological properties of TIQ derivatives are expected to contribute to the development of new therapeutic agents for treating Parkinson's disease. In the present study, we describe more efficient synthesis methods for TIQ derivatives via Pummerer-type cyclization of the substrate N-acyl sulfoxide. Furthermore, the modified Pummerer reaction provided a convenient and efficient method for synthesizing various TIQs. TIQ and its derivative, 1-benzyl-TIQ, can induce parkinsonism in primates and rodents. On the other hand, one TIQ derivative, 1-methyl-TIQ, has been shown to prevent MPTP, TIQ, and 1-benzyl-TIQ induced behavioral abnormalities. Therefore, TIQ derivatives are considered to play an important role in both the onset and prevention of Parkinson's disease. In this article, we focus on the synthesis and pharmacological aspects of 1,2,3,4-tetrahydroisoquinoline derivatives in Parkinson's disease.

収録刊行物

参考文献 (157)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ